From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine (Q28067029)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine	scientific article

Statements

scholarly article

1 reference

1 reference

Europe PubMed Central

From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine (English)

1 reference

personalized medicine

1 reference

based on heuristic

inferred from title

metabolic profiling

1 reference

based on heuristic

inferred from title

author name string

Jeremy R. Everett

1

1 reference

language of work or name

1 reference

publication date

8 September 2016

1 reference

Frontiers in Pharmacology

1 reference

7

1 reference

297

1 reference

Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Pharmacometabolomics reveals racial differences in response to atenolol treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Personalized medicine: hope or hype?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Genome-wide association study identifies multiple loci influencing human serum metabolite levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Human metabolic individuality in biomedical and pharmaceutical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Pharmacometabolomic approach to predict QT prolongation in guinea pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

20 March 2017

Metabolomics – the link between genotypes and phenotypes

2 references

https://api.crossref.org/works/10.3389/FPHAR.2016.00297

22 April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

7 April 2017

Metabolite profiles and the risk of developing diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

7 April 2017

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

7 April 2017

Pharmacometabolomics informs Pharmacogenomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Endogenous metabolites that are substrates of organic anion transporter's (OATs) predict methotrexate clearance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

NMR-based metabonomic analysis of normal rat urine and faeces in response to (±)-venlafaxine treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

A Pharmacometabonomic Approach To Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabonomics in humans: a new tool for personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Blood Metabolomic Predictors of 1-Year Outcome in Subarachnoid Hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Addressing phenoconversion: the Achilles' heel of personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

An atlas of genetic influences on human blood metabolites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

The emerging era of pharmacogenomics: current successes, future potential, and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

The pharmacogenetics of type 2 diabetes: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacogenetics at 50: genomic personalization comes of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacogenomic testing and personalized treatment of depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabonomics and personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

A genome-wide association study of the human metabolome in a community-based cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Statistical spectroscopic tools for biomarker discovery and systems medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Novel biomarkers for pre-diabetes identified by metabolomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

A genome-wide association study of metabolic traits in human urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Metabolic phenotyping in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Pharmaco-metabonomic phenotyping and personalized drug treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

The Personalized Medicine Coalition: goals and strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Human sulfotransferases and their role in chemical metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Sulfation through the looking glass--recent advances in sulfotransferase research for the curious

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

29 September 2017

Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

2 June 2018

Variability of acetaminophen metabolism in Caucasians and Orientals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5014868

2 June 2018

A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Serum molecular signatures of weight change during early breast cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Prediction of variability in CYP3A4 induction using a combined 1H NMR metabonomics and targeted UPLC-MS approach.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance.

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Pharmacometabonomic Investigation of Dynamic Metabolic Phenotypes Associated with Variability in Response to Galactosamine Hepatotoxicity

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Pharmacometabonomic Characterization of Xenobiotic and Endogenous Metabolic Phenotypes That Account for Inter-individual Variation in Isoniazid-Induced Toxicological Response

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Pharmacometabonomics and Predictive Metabonomics

1 reference

https://api.crossref.org/works/10.3389%2FFPHAR.2016.00297

21 January 2018

Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/27660611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/27660611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias

1 reference

https://pubmed.ncbi.nlm.nih.gov/27660611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28067029&oldid=1966557621"